MACROCYCLIC COMPOUNDS AND THEIR USE AS KINASE INHIBITORS
申请人:Combs Andrew Paul
公开号:US20090286778A1
公开(公告)日:2009-11-19
The present invention relates to macrocyclic compounds of Formula I:
or pharmaceutically acceptable salts thereof or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are JAK/ALK inhibitors useful in the treatment of JAK/ALK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.
A Green, Solvent-Free, Microwave-Assisted, High-Yielding YbCl<sub>3</sub>Catalyzed Deprotection of THP/MOM/Ac/Ts Ethers of Chalcone Epoxide and 2′-Aminochalcone and Their Sequel Cyclization
作者:Sumit Kumar、Nishant Verma、Iram Parveen、Naseem Ahmed
DOI:10.1002/jhet.2517
日期:2016.11
Under microwave and solvent‐free conditions, YbCl3 efficiently catalyzed the deprotection of tetrahydropyran‐2‐yl, methoxymethyl (MOM), acetyl, and tosyl groups and sequelcyclization of chalconeepoxide to 2‐hydroxyindanone and 2′‐aminochalcone to aza‐flavanone. The reaction afforded the products in excellent yield (78–99%) at 850 W microwave heating within 1–5 min under eco‐friendly conditions. The
Triazole derivatives and pharmaceutical compositions containing the derivatives are disclosed as being useful in inhibiting the activity of the receptor protein tyrosine kinase Axl. Methods of using the derivatives in treating diseases or conditions associated with Axl catalytic activity are also disclosed.
Methods of using triazole derivatives in treating diseases or conditions associated with Axl catalytic activity are disclosed.
本发明揭示了使用三唑衍生物治疗与Axl催化活性相关的疾病或病症的方法。
Macrocyclic compounds and their use as kinase inhibitors
申请人:Combs Andrew Paul
公开号:US08871753B2
公开(公告)日:2014-10-28
The present invention relates to macrocyclic compounds of Formula I:
or pharmaceutically acceptable salts thereof or quaternary ammonium salts thereof wherein constituent members are provided hereinwith, as well as their compositions and methods of use, which are JAK/ALK inhibitors useful in the treatment of JAK/ALK-associated diseases including, for example, inflammatory and autoimmune disorders, as well as cancer.